Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets

Transcriptional Control by NF-κB: Elongation in Focus

(2013) Gil Diamant et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab

(2013) S. Ithimakin et al.   CANCER RESEARCH

Gamma-irradiation induces HER-2/neuoverexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab

(2013) Ioannis F. Voutsas et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

(2013) Silvia C. Formenti et al.   JNCI-Journal of the National Cancer Institute

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

(2013) John Stagg et al.   Therapeutic Advances in Medical Oncology

Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer

(2012) M. S. N. Mohd Sharial et al.   ANNALS OF ONCOLOGY

HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

(2012) N. Duru et al.   CLINICAL CANCER RESEARCH

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

(2012) Ana Markovic et al.   Expert Review of Anticancer Therapy

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer

(2012) Anna R. Kwilas   Frontiers in Oncology

Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines

(2011) D. M. Collins et al.   ANNALS OF ONCOLOGY

Activity and resistance of trastuzumab according to different clinical settings

(2011) Elda Tagliabue et al.   CANCER TREATMENT REVIEWS

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

(2011) J. W. Friedberg   Hematology-American Society of Hematology Education Program

Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis

(2010) Olivier Gavet et al.   DEVELOPMENTAL CELL

HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells

(2010) R Shimizu et al.   LEUKEMIA

Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited

(2010) Frank Pajonk et al.   STEM CELLS

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

(2009) Teemu T. Junttila et al.   CANCER CELL

Monoclonal antibodies for cancer immunotherapy

(2009) Louis M Weiner et al.   LANCET

Correlation between NK function and response to trastuzumab in metastatic breast cancer patients

(2008) Alessandra Beano et al.   Journal of Translational Medicine

Refinement of the Dichlorofluorescein Assay for Flow Cytometric Measurement of Reactive Oxygen Species in Irradiated and Bystander Cell Populations

(2008) Kurt Hafer et al.   RADIATION RESEARCH

NF-κB-MediatedHER2Overexpression inRadiation-Adaptive Resistance

(2008) Ning Cao et al.   RADIATION RESEARCH